These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30853789)

  • 41. Rare variants in the promoter of the fragile X syndrome gene (FMR1).
    Milà M; Castellví-Bel S; Sánchez A; Barceló A; Badenas C; Mallolas J; Estivill X
    Mol Cell Probes; 2000 Apr; 14(2):115-9. PubMed ID: 10799273
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Point mutation frequency in the FMR1 gene as revealed by fragile X syndrome screening.
    Handt M; Epplen A; Hoffjan S; Mese K; Epplen JT; Dekomien G
    Mol Cell Probes; 2014; 28(5-6):279-83. PubMed ID: 25171808
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential increases of specific FMR1 mRNA isoforms in premutation carriers.
    Pretto DI; Eid JS; Yrigollen CM; Tang HT; Loomis EW; Raske C; Durbin-Johnson B; Hagerman PJ; Tassone F
    J Med Genet; 2015 Jan; 52(1):42-52. PubMed ID: 25358671
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reciprocal changes in DNA methylation and hydroxymethylation and a broad repressive epigenetic switch characterize FMR1 transcriptional silencing in fragile X syndrome.
    Brasa S; Mueller A; Jacquemont S; Hahne F; Rozenberg I; Peters T; He Y; McCormack C; Gasparini F; Chibout SD; Grenet O; Moggs J; Gomez-Mancilla B; Terranova R
    Clin Epigenetics; 2016; 8():15. PubMed ID: 26855684
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells.
    Coffee B; Zhang F; Warren ST; Reines D
    Nat Genet; 1999 May; 22(1):98-101. PubMed ID: 10319871
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alteration of expression of muscle specific isoforms of the fragile X related protein 1 (FXR1P) in facioscapulohumeral muscular dystrophy patients.
    Davidovic L; Sacconi S; Bechara EG; Delplace S; Allegra M; Desnuelle C; Bardoni B
    J Med Genet; 2008 Oct; 45(10):679-85. PubMed ID: 18628314
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuropsychiatric symptoms of fragile X syndrome: pathophysiology and pharmacotherapy.
    Tsiouris JA; Brown WT
    CNS Drugs; 2004; 18(11):687-703. PubMed ID: 15330685
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tissue and developmental regulation of fragile X mental retardation 1 exon 12 and 15 isoforms.
    Xie W; Dolzhanskaya N; LaFauci G; Dobkin C; Denman RB
    Neurobiol Dis; 2009 Jul; 35(1):52-62. PubMed ID: 19362146
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of the human fragile X mental retardation 1 polymerase chain reaction reagents to amplify the FMR1 gene: testing in a clinical diagnostic laboratory.
    Nahhas FA; Monroe TJ; Prior TW; Botma PI; Fang J; Snyder PJ; Talbott SL; Feldman GL
    Genet Test Mol Biomarkers; 2012 Mar; 16(3):187-92. PubMed ID: 21992462
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein.
    Siomi H; Siomi MC; Nussbaum RL; Dreyfuss G
    Cell; 1993 Jul; 74(2):291-8. PubMed ID: 7688265
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A female compound heterozygote (pre- and full mutation) for the CGG FMR1 expansion.
    Milà M; Castellví-Bel S; Giné R; Vazquez C; Badenas C; Sánchez A; Estivill X
    Hum Genet; 1996 Oct; 98(4):419-21. PubMed ID: 8792815
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alternatively spliced products lacking exon 12 dominate the expression of fragile X mental retardation 1 gene in human tissues.
    Fu X; Zheng D; Liao J; Li Q; Lin Y; Zhang D; Yan A; Lan F
    Mol Med Rep; 2015 Aug; 12(2):1957-62. PubMed ID: 25847585
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The fragile X mental retardation 1 gene (FMR1): historical perspective, phenotypes, mechanism, pathology, and epidemiology.
    Grigsby J
    Clin Neuropsychol; 2016 Aug; 30(6):815-33. PubMed ID: 27356167
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An origin of DNA replication in the promoter region of the human fragile X mental retardation (FMR1) gene.
    Gray SJ; Gerhardt J; Doerfler W; Small LE; Fanning E
    Mol Cell Biol; 2007 Jan; 27(2):426-37. PubMed ID: 17101793
    [TBL] [Abstract][Full Text] [Related]  

  • 55. X inactivation of the FMR1 fragile X mental retardation gene.
    Kirchgessner CU; Warren ST; Willard HF
    J Med Genet; 1995 Dec; 32(12):925-9. PubMed ID: 8825916
    [TBL] [Abstract][Full Text] [Related]  

  • 56. microRNAs and Fragile X Syndrome.
    Lin SL
    Adv Exp Med Biol; 2015; 888():107-21. PubMed ID: 26663181
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fragile X mental retardation syndrome: from pathogenesis to diagnostic issues.
    Mandel JL; Biancalana V
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S158-65. PubMed ID: 15135801
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular diagnosis of fragile X syndrome using methylation sensitive techniques in a cohort of patients with intellectual disability.
    Chaudhary AG; Hussein IR; Abuzenadah A; Gari M; Bassiouni R; Sogaty S; Lary S; Al-Quaiti M; Al Balwi M; Al Qahtani M
    Pediatr Neurol; 2014 Apr; 50(4):368-76. PubMed ID: 24630283
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Heterogeneity of clinical characteristics of FMR1-related disorders].
    Pereverzeva DS; Tyushkevich SA; Gorbachevskaya NL; Mamokhina UA; Danilina KK
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(7):103-111. PubMed ID: 31464297
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Astrocytic Contributions to Synaptic and Learning Abnormalities in a Mouse Model of Fragile X Syndrome.
    Hodges JL; Yu X; Gilmore A; Bennett H; Tjia M; Perna JF; Chen CC; Li X; Lu J; Zuo Y
    Biol Psychiatry; 2017 Jul; 82(2):139-149. PubMed ID: 27865451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.